Document:

nvcr-ex102_29.htm

Exhibit 10.2

NOVOCURE LIMITED

Form of

Non-Qualified Stock Option Agreement

Pursuant to the

NovoCure Limited

2015 Omnibus Incentive Plan

AGREEMENT (this “Agreement”), dated as of [__________] between NovoCure Limited, a Jersey Isle company (the “Company” and, collectively with its controlled Affiliates, the “ Employer”), and [________]  (the “Participant”).

Preliminary Statement

The Committee hereby grants this non-qualified stock option (the “Stock Option”) on [_________] (the “Grant Date ”) pursuant to the NovoCure Limited 2015 Omnibus Incentive Plan, as it may be amended from time to time (the “ Plan ”), to purchase the number of Ordinary Shares set forth below to the Participant, as an Eligible Employee, Consultant or Non-Employee Director. Except as otherwise indicated, any capitalized term used but not defined herein shall have the meaning ascribed to such term in the Plan. By signing and returning this Agreement, the Participant acknowledges having received and read a copy of the Plan and agrees to comply with it, this Agreement and all applicable laws and regulations.

Accordingly, the parties hereto agree as follows:

1. Tax Matters. No part of the Stock Option is intended to qualify as an “incentive stock option” under Section 422 of the Code.

2. Grant of Stock Option. Subject to the Plan and the terms and conditions set forth herein and therein, the Participant is hereby granted the Stock Option to purchase from the Company [__________] Ordinary Shares at a price per share of $[__________] (the “ Exercise Price ”).

3. Vesting.

(a) Vesting Schedule. The Stock Option shall vest and become exercisable on [insert, as applicable, vesting date(s) and/or event(s)][([the/each, a] “Vesting Date”)] if [insert, as applicable, performance target(s) and any related measurement criteria][; provided, that the Participant has not experienced a Termination prior to the Vesting Date.]  [There shall be no proportionate or partial vesting prior to the Vesting Date.] 

[(b)Change in Control.  [If applicable, insert change in control provisions.]]  

(c)Unvested Stock Options.  Any portion of the Stock Option that is not vested as of or upon the date of a Participant’s Termination for any reason shall terminate and expire on the date of such Termination. 

4. Exercise.

(a) To the extent that the Stock Option has become vested and exercisable with respect to a 

 

 

number of Ordinary Shares, the Stock Option may thereafter be exercised by the Participant, in whole or in part, at any time or from time to time prior to the expiration of the Stock Option in accordance with the Plan. The Participant may exercise the Stock Option by delivering to the Company written notice of the number of Ordinary Shares covered by the exercise, together with the aggregate Exercise Price. Payment may be made by: (i) cash, check, bank draft or money order payable to the order of the Company; (ii) solely to the extent permitted by applicable law, through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable to the Company to deliver promptly to the Company an amount equal to the aggregate Exercise Price; or (iii) on such other terms and conditions as may be acceptable to the Committee. Upon expiration of the Stock Option, the Stock Option shall be canceled and no longer exercisable.

(b) Unless otherwise directed or permitted by the Committee, the Participant must pay or provide for all applicable withholding taxes in respect of the exercise of the Stock Option by (i) remitting the aggregate amount of such taxes to the Company in full, by cash, check, bank draft or money order payable to the order of the Company; (ii) to the extent permitted by the Committee, by making arrangements with the Company to have such taxes withheld from other compensation due to Participant; or (iii) solely to the extent permitted by applicable law and authorized by the Committee, through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably acceptable to the Company to deliver promptly to the Company an amount equal to the applicable withholding taxes.

(c) Upon the exercise of the Stock Option, the Participant:

(i) will be deemed to acknowledge and make such representations and warranties as may be requested by the Company for compliance with applicable laws, and any issuances of Ordinary Shares by the Company shall be made in reliance upon the express representations and warranties of the Participant; and

(ii) will not sell, transfer or otherwise dispose of the Ordinary Shares in violation of the Plan or this Agreement or dispose of the Ordinary Shares unless and until the Participant has complied with all requirements of this Agreement applicable to the disposition of the Ordinary Shares.

(d) Pursuant to the Plan, in the event the Participant engages in Detrimental Activity prior to any exercise of the Stock Option, the Stock Option shall thereupon terminate and expire. As a condition of the exercise of the Stock Option, the Participant shall be required to certify in a manner acceptable to the Company (or shall be deemed to have certified) that the Participant is in compliance with the terms and conditions of the Plan and that the Participant has not engaged in, and does not intend to engage in, any Detrimental Activity. In the event the Participant engages in Detrimental Activity during the one-year period commencing on the date the Stock Option is exercised, the Company shall be entitled to recover from the Participant, at any time within one year after such Detrimental Activity, and the Participant shall pay over to the Company, the Ordinary Shares received from such exercise, or, if such Ordinary Shares have been transferred, an amount equal to Fair Market Value of such Ordinary Shares on the date of such exercise.

(e) The restrictions regarding Detrimental Activity are necessary for the protection of the business and goodwill of the Company and are considered by the Participant to be reasonable for such purposes. Without intending to limit the legal or equitable remedies available in the Plan and in this Agreement, the Participant acknowledges that engaging in Detrimental Activity will cause the Company material irreparable injury for which there is no adequate remedy at law, that it will not be possible to measure damages for such injuries precisely and that, in the event of such activity or threat thereof, the Company shall be entitled, in addition to the remedies provided under the Plan, to obtain from any court 

2

 

 

of competent jurisdiction a temporary restraining order or a preliminary or permanent injunction restraining the Participant from engaging in Detrimental Activity or such other relief as may be required to specifically enforce any of the covenants in the Plan and this Agreement without the necessity of posting a bond, and in the case of a temporary restraining order or a preliminary injunction, without having to prove special damages.

5. Stock Option Term. The term of the Stock Option shall be until the [__________] anniversary of the Grant Date, after which time it shall expire (the “Expiration Date”) [, subject to [if applicable, insert any relevant early termination provisions]] or the Participant’s Termination as specified in the Plan and this Agreement. Notwithstanding anything herein to the contrary, upon the Expiration Date, the Stock Option (whether vested or not) shall be immediately forfeited, canceled and terminated for no consideration and no longer shall be exercisable. The Stock Option is subject to termination prior to the Expiration Date to the extent provided in the Plan or this Agreement.

6. Termination and Change in Control. The provisions in the Plan regarding Termination and Change in Control shall apply to the Stock Option.

7. Restriction on Transfer of Stock Option. The provisions in the Plan regarding restrictions on Transfer shall apply to the Stock Option.

8. No Rights as a Stockholder. The Participant shall not have any rights as a stockholder of the Company with respect to any Award until the Participant becomes the holder of record of the Ordinary Shares underlying the Award.

9. Provisions of Plan Control. This Agreement is subject to all the terms, conditions and provisions of the Plan, including the amendment provisions thereof, and to such rules, regulations and interpretations relating to the Plan as may be adopted by the Committee and as may be in effect from time to time. The Plan is incorporated herein by reference. If and to the extent that this Agreement conflicts or is inconsistent with the Plan, the Plan shall control, and this Agreement shall be deemed to be modified accordingly.

10. Notices. All notices, demands or requests made pursuant to, under or by virtue of this Agreement must be in writing and sent to the party to which the notice, demand or request is being made:

(a) unless otherwise specified by the Company in a notice delivered by the Company in accordance with this Section 10 , any notice required to be delivered to the Company shall be properly delivered if delivered to:

NovoCure Limited

20 Valley Stream Pkwy

Suite 300

Malvern, PA 19355

Attention:         General Counsel

Telephone:       (212) 767-7530

(b) if to the Participant, to the address on file with the Employer.

Any notice, demand or request, if made in accordance with this Section 10 shall be deemed to have been duly given: (i) when delivered in person; (ii) three days after being sent by United States mail; or (iii) on the first business day following the date of deposit if delivered by a nationally recognized overnight delivery service.

3

 

 

11. No Right to Employment/Consultancy/Directorship. This Agreement shall not give the Participant or other Person any right to employment, consultancy or directorship by the Employer, or limit in any way the right of the Employer to terminate the Participant’s employment, consultancy or directorship at any time.

12. Waiver of Jury Trial. EACH PARTY TO THIS AGREEMENT, FOR ITSELF AND ITS AFFILIATES, HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THE ACTIONS OF THE PARTIES HERETO OR THEIR RESPECTIVE AFFILIATES PURSUANT TO THE PLAN OR THIS AGREEMENT OR IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT OF THE PLAN OR THIS AGREEMENT.

13. Severability of Provisions. If at any time any of the provisions of this Agreement shall be held invalid or unenforceable, or are prohibited by the laws of the jurisdiction where they are to be performed or enforced, by reason of being vague or unreasonable as to duration or geographic scope or scope of the activities restricted, or for any other reason, such provisions shall be considered divisible and shall become and be immediately amended to include only such restrictions and to such extent as shall be deemed to be reasonable and enforceable by the court or other body having jurisdiction over this Agreement and the Company and the Participant agree that the provisions of this Agreement, as so amended, shall be valid and binding as though any invalid or unenforceable provisions had not been included.

 

14. Governing Law. All matters arising out of or relating to this Agreement and the transactions contemplated hereby, including its validity, interpretation, construction, performance and enforcement, shall be governed by and construed in accordance with the internal laws of the Jersey Isles, without giving effect to its principles of conflict of laws.

15. Section 409A. The Stock Option is intended to be exempt from the applicable requirements of Section 409A and shall be limited, construed and interpreted in accordance with such intent;  provided , that the Employer does not guarantee to the Participant any particular tax treatment of the Stock Option. In no event whatsoever shall the Employer be liable for any additional tax, interest or penalties that may be imposed on the Participant by Section 409A or any damages for failing to comply with Section 409A.

16. Interpretation. Unless a clear contrary intention appears: (a) the defined terms herein shall apply equally to both the singular and plural forms of such terms; (b) reference to any Person includes such Person’s successors and assigns but, if applicable, only if such successors and assigns are not prohibited by the Plan or this Agreement, and reference to a Person in a particular capacity excludes such Person in any other capacity or individually; (c) any pronoun shall include the corresponding masculine, feminine and neuter forms; (d) reference to any agreement, document or instrument means such agreement, document or instrument as amended or modified and in effect from time to time in accordance with the terms thereof; (e) reference to any law, rule or regulation means such law, rule or regulation as amended, modified, codified, replaced or reenacted, in whole or in part, and in effect from time to time, including rules and regulations promulgated thereunder, and reference to any section or other provision of any law, rule or regulation means that provision of such law, rule or regulation from time to time in effect and constituting the substantive amendment, modification, codification, replacement or reenactment of such section or other provision; (f) “hereunder,” “hereof,” “hereto,” and words of similar import shall be deemed references to this Agreement as a whole and not to any particular article, section or other provision hereof; (g) numbered or lettered articles, sections and subsections herein contained refer to articles, sections and subsections of this Agreement; (h) “including” (and with correlative meaning 

4

 

 

“include”) means including without limiting the generality of any description preceding such term; (i) “or” is used in the inclusive sense of “and/or”; (j) references to documents, instruments or agreements shall be deemed to refer as well to all addenda, exhibits, schedules or amendments thereto; and (k) reference to dollars or $ shall be deemed to refer to U.S. dollars.

17. No Strict Construction. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted.

[Remainder of Page Left Intentionally Blank]

 

5

 

 

IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first above written.

 

			
	
 
	
 
	
 

	
NOVOCURE LIMITED

	
 
	
 

	
By:
	
 
	
 

	
Name:
	
 
	
 

	
Title:
	
 
	
 

 

			
	
 
	
 
	
 

	
PARTICIPANT

	
 
	
 

	
By:
	
 
	
 

	
Name:
	
 
	
 

	
Employee Address:

 

6ren-ex41_6.htm

Exhibit 4.1

 

Resolute Energy Corporation
Issuer

8.50% Senior Notes Due 2020

SUPPLEMENTAL INDENTURE
Dated as of May 12, 2017

Delaware Trust Company
Trustee

 

 

 

SUPPLEMENTAL INDENTURE

SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of May 12, 2017, among Resolute Energy Corporation, a Delaware corporation (the “Company”), the subsidiary guarantors listed on the signature pages hereto (the “Guarantors”) and Delaware Trust Company (as successor to U.S. Bank, National Association), as trustee (the “Trustee”).

W I T N E S S E T H:

WHEREAS, the Company and the Guarantors have heretofore executed and delivered to the Trustee an indenture, dated as of April 25, 2012 (as amended or supplemented to the date hereof, the “Indenture”), providing for the issuance of 8.50% Senior Notes due 2020 (the “Notes”);

WHEREAS, on April 25, 2012, the Company issued $250,000,000 in principal amount of Notes;

WHEREAS, on December 10, 2012, the Company issued $150,000,000 in principal amount of Additional Notes;

WHEREAS, the Company has entered into that certain Purchase Agreement, dated May 9, 2017, by and among the Company, the Guarantors and BMO Capital Markets Corp., as representative of the several initial purchasers named therein, pursuant to which, on the date hereof, the Company is issuing $125,000,000 of Additional Notes as permitted by Section 2.16  and Section 4.07 of the Indenture (the “May 2017 Additional Notes”); and

WHEREAS, pursuant to Section 9.01(a)(ix) of the Indenture, the Trustee, the Company and the Guarantors are authorized to execute and deliver this Supplemental Indenture without the consent of any Holder of Notes.

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Guarantors and the Trustee mutually covenant and agree for the equal and ratable benefit of the holders of the Notes as follows:

1.Definitions; Construction.

For all purposes of this Supplemental Indenture, except as otherwise herein expressly provided or unless the context otherwise requires: (i) the terms and expressions used herein shall have the same meanings as corresponding terms and expressions used in the Indenture; and (ii) the words “herein,” “hereof” and “hereby” and other words of similar import used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any particular section hereof.

2.May 2017 Additional Notes.

(a)The Company hereby represents and warrants that attached hereto as Annex A is a true and correct copy of the Officers’ Certificate required by Section 12.04 of the Indenture in connection with the issuance of the May 2017 Additional Notes. 

(b)The definition of the term “Additional Notes” set forth in the Indenture is hereby supplemented by adding the following sentence at the end of such definition: “For the avoidance of doubt “Additional Notes” shall include those Notes issued on May 12, 2017 by the Company in an aggregate principal amount of $125,000,000, as more particularly described in the Supplemental Indenture hereto, dated as of May 12, 2017.”

(c)The Company hereby represents and warrants that the issuance of the May 2017 Additional Notes is in compliance with, and, otherwise authorized and permitted, by Section 2.16 and Section 4.07 of the Indenture.

(d)The May 2017 Additional Notes will be (A) Certificate Number A-1 (CUSIP No. 76116A AD0 / ISIN No. US76116AAD00) in the aggregate principal amount of $125,000,000; and (B) Certificate Number S-1 (CUSIP No. U76174 AD0/ ISIN No. USU76174AD08) in the aggregate principal amount of $0.

(e)The May 2017 Additional Notes will be issued at an issue price of 101.625% plus accrued interest from and including May 1, 2017 to, but excluding, the date hereof.

(f)The first Interest Payment Date of the May 2017 Additional Notes will be November 1, 2017.

(g)The May 2017 Additional Notes will be in the form of the Initial Notes and will be subject to a registration rights agreement relating to such Additional Notes (the “Registration Rights Agreement”).

3.Governing Law. THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

4.No Personal Liability of Directors, Officers, Employees and Stockholders. No director, officer, employee, incorporator or stockholder of the Company or any Guarantor, as such, shall have any liability for any obligations of the Company or any guarantor under the Notes (including the May 2017 Additional Notes), the Indenture, this Supplemental Indenture, any Subsidiary Guarantees or the Registration Rights Agreement or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting the May 2017 Additional Notes waives and releases all such liability. The waiver and release are part of the consideration for issuance of the May 2017 Additional Notes.

5.The Trustee. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company and the Guarantors.

6.Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.

7.Effect of Headings. The Section headings herein are for convenience only and shall not effect the construction thereof.

[SIGNATURE PAGE FOLLOWS]

 

 

 

IN WITNESS WHEREOF, the parties have caused this Supplemental Indenture to be duly executed as of the date first written above.

	
 
	
 
	
COMPANY

	
 
	
 
	
 

	
 
	
 
	
RESOLUTE ENERGY CORPORATION

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

 

	
 
	
 
	
GUARANTORS

	
 
	
 
	
 

	
 
	
 
	
RESOLUTE NATURAL RESOURCES COMPANY, LLC

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

 

	
 
	
 
	
WYNR, LLC

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

	
 
	
 
	
BWNR, LLC

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

 

 

[Signature Page to First Supplemental Indenture]

 

	
 
	
 
	
RESOLUTE WYOMING, INC.

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

	
 
	
 
	
HICKS ACQUISITION COMPANY I, INC.

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

	
 
	
 
	
RESOLUTE ANETH, LLC

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

	
 
	
 
	
RESOLUTE NORTHERN ROCKIES, LLC

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

 

	
 
	
 
	
RESOLUTE NATURAL RESOURCES SOUTHWEST, LLC

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

 

 

[Signature Page to First Supplemental Indenture]

 

 

	
 
	
 
	
DELAWARE TRUST COMPANY, as Trustee

	
 
	
 
	
 

	
 
	
 
	
 

	
 
	
 
	
By:
	
 
	
/s/ Alan R. Halpern

	
 
	
 
	
 
	
 
	
Name: Alan R. Halpern

	
 
	
 
	
 
	
 
	
Title: Vice President

 

 

 

[Signature Page to First Supplemental Indenture]

 

 

ANNEX A

 

OFFICERS’ CERTIFICATE

 

26

OFFICERS’ CERTIFICATE TO TRUSTEE 

May 12, 2017

The undersigned, Chief Executive Officer and Executive Vice President and Chief Financial Officer, respectively, of Resolute Energy Corporation, a Delaware corporation (the “Company”), hereby certify that:

	
1.
	
This Certificate is delivered to Delaware Trust Company (successor trustee to U.S. Bank National Association) (the “Trustee”), as trustee, pursuant to Sections 12.04 and 12.05 of the Indenture, dated as of April 25, 2012, by and among the Company, the guarantors named on the signature pages thereof and the Trustee, as supplemented by the Supplemental Indenture, dated May 12, 2017 (the “Indenture”) in connection with the authentication and delivery (the “Authentication”) by the Trustee of $125,000,000 aggregate principal amount of the Company’s 8.50% Senior Notes due 2020 (the “Notes”) in accordance with the Authentication Order dated May 12, 2017 (the “Authentication Order”) of the Company pursuant to Section 2.02 of the Indenture.

 

	
2.
	
The undersigned have read the Indenture, including, but not limited to, Sections 2.01, 2.02, 2.07, 2.11, 2.16, 4.07, 12.04 and 12.05 thereof, and the definitions in such Indenture relating thereto.

 

	
3.
	
The statements made herein are based either upon the personal knowledge of the persons making this Certificate or on information, data and reports furnished to such persons by the officers, counsel, department heads or employees of the Company who have knowledge of the facts involved.

 

	
4.
	
The undersigned have examined the Authentication Order and the Supplemental Indenture and the covenants, conditions and provisions of the Indenture relating thereto.

 

	
5.
	
The undersigned have reviewed such other corporate documents and records relating to the matters referred to herein and have made such other examination or investigation as, in the opinion of the undersigned, is necessary to enable the undersigned to express an informed opinion as to whether or not all covenants or conditions precedent, if any, provided for in the Indenture with respect to the Authentication have been satisfied.

 

	
6.
	
In the opinion of the undersigned, all covenants or conditions precedent, if any, provided in the Indenture relating to the Authentication have been satisfied, and such Notes may be delivered in accordance with the Authentication Order as provided in the Indenture.

 

	
7.
	
In the opinion of the undersigned the Authentication is in compliance with, and, otherwise authorized and permitted, by Section 2.16 and Section 4.07 of the Indenture.

 

	
8.
	
Attached as Annex A, respectively, hereto are true, correct and complete copies of the resolutions adopted by the Board of Directors of the Company (the “Board”) on May 8, 2017, and such resolutions have not been modified or amended and remain in full force and effect as of the date hereof.

 

 

 

IN WITNESS WHEREOF, the undersigned have executed this Officers’ Certificate as of the date set forth above.

 

	
 
	
 
	
By:
	
 
	
/s/ Richard F. Betz

	
 
	
 
	
 
	
 
	
Name: Richard F. Betz

	
 
	
 
	
 
	
 
	
Title: Chief Executive Officer

 

	
 
	
 
	
By:
	
 
	
/s/ Theodore Gazulis

	
 
	
 
	
 
	
 
	
Name: Theodore Gazulis,

	
 
	
 
	
 
	
 
	
Title: Executive Vice President and Chief Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}]]